JP4080541B2
(ja)
|
1996-10-18 |
2008-04-23 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
セリンプロテアーゼ、特にc型肝炎ウイルスns3プロテアーゼの阻害因子
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
US7601709B2
(en)
|
2003-02-07 |
2009-10-13 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic hepatitis C serine protease inhibitors
|
US7176208B2
(en)
|
2003-04-18 |
2007-02-13 |
Enanta Pharmaceuticals, Inc. |
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
|
US7273851B2
(en)
|
2003-06-05 |
2007-09-25 |
Enanta Pharmaceuticals, Inc. |
Tri-peptide hepatitis C serine protease inhibitors
|
WO2004113365A2
(fr)
*
|
2003-06-05 |
2004-12-29 |
Enanta Pharmaceuticals, Inc. |
Inhibiteurs de la tripeptide hepatite c serine protease
|
US7125845B2
(en)
|
2003-07-03 |
2006-10-24 |
Enanta Pharmaceuticals, Inc. |
Aza-peptide macrocyclic hepatitis C serine protease inhibitors
|
KR20060085248A
(ko)
*
|
2003-09-26 |
2006-07-26 |
쉐링 코포레이션 |
C형 간염 바이러스 ns3 세린 프로테아제의마크로사이클릭 억제제
|
CA2541634A1
(fr)
|
2003-10-10 |
2005-04-28 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs de serine proteases, en particulier la ns3-ns4a protease du hcv
|
AR048401A1
(es)
|
2004-01-30 |
2006-04-26 |
Medivir Ab |
Inhibidores de la serina-proteasa ns3 del vhc
|
AU2005212257A1
(en)
|
2004-02-04 |
2005-08-25 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
US7582770B2
(en)
|
2004-02-20 |
2009-09-01 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
MX2007007590A
(es)
*
|
2004-12-22 |
2007-12-10 |
Ambrx Inc |
Composiciones que contienen, metodos que involucran y usos de aminoacidos no naturales y polipeptidos.
|
US7323447B2
(en)
|
2005-02-08 |
2008-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CN101160317B
(zh)
*
|
2005-03-08 |
2013-03-27 |
贝林格尔·英格海姆国际有限公司 |
制备大环化合物的方法
|
US7592336B2
(en)
|
2005-05-10 |
2009-09-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7601686B2
(en)
|
2005-07-11 |
2009-10-13 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
TWI387603B
(zh)
*
|
2005-07-20 |
2013-03-01 |
Merck Sharp & Dohme |
Hcv ns3蛋白酶抑制劑
|
JP5249028B2
(ja)
|
2005-07-25 |
2013-07-31 |
インターミューン・インコーポレーテッド |
C型肝炎ウイルス複製の新規大環状阻害剤
|
ATE496042T1
(de)
|
2005-07-29 |
2011-02-15 |
Tibotec Pharm Ltd |
Makrocyclische inhibitoren des hepatitis-c-virus
|
MX2008001402A
(es)
*
|
2005-07-29 |
2008-04-04 |
Tibotec Pharm Ltd |
Inhibidores macrociclicos del virus de la hepatitis c.
|
TWI375670B
(en)
|
2005-07-29 |
2012-11-01 |
Tibotec Pharm Ltd |
Macrocylic inhibitors of hepatitis c virus
|
CN101273042B
(zh)
|
2005-07-29 |
2013-11-06 |
泰博特克药品有限公司 |
丙型肝炎病毒的大环抑制剂
|
PE20070211A1
(es)
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
CN101273030B
(zh)
|
2005-07-29 |
2012-07-18 |
泰博特克药品有限公司 |
丙型肝炎病毒的大环抑制剂
|
PE20070343A1
(es)
*
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Inhibidores macrociclicos del virus de la hepatitis c
|
TW200745061A
(en)
|
2005-07-29 |
2007-12-16 |
Tibotec Pharm Ltd |
Macrocylic inhibitors of hepatitis C virus
|
AU2006275413B2
(en)
|
2005-08-02 |
2012-07-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
EP1915378A4
(fr)
|
2005-08-12 |
2009-07-22 |
Boehringer Ingelheim Int |
Inhibiteurs de polymerase virale
|
EP2357170A1
(fr)
|
2005-08-19 |
2011-08-17 |
Vertex Pharmaceuticals Incorporated |
Procédés et intermédiaires
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
DE602006019323D1
(de)
|
2005-10-11 |
2011-02-10 |
Intermune Inc |
Verbindungen und verfahren zur inhibierung der replikation des hepatitis-c-virus
|
US7772183B2
(en)
|
2005-10-12 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7741281B2
(en)
|
2005-11-03 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7705138B2
(en)
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
EP1951748B1
(fr)
|
2005-11-11 |
2013-07-24 |
Vertex Pharmaceuticals, Inc. |
Variantes du virus de l'hépatite c
|
US7816348B2
(en)
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US9526769B2
(en)
|
2006-06-06 |
2016-12-27 |
Enanta Pharmaceuticals, Inc. |
Macrocylic oximyl hepatitis C protease inhibitors
|
US20070281884A1
(en)
*
|
2006-06-06 |
2007-12-06 |
Ying Sun |
Macrocyclic oximyl hepatitis C protease inhibitors
|
US8268776B2
(en)
|
2006-06-06 |
2012-09-18 |
Enanta Pharmaceuticals, Inc. |
Macrocylic oximyl hepatitis C protease inhibitors
|
UY30437A1
(es)
|
2006-06-26 |
2008-01-31 |
Enanta Pharm Inc |
Quinoxalinil macroceclicos inhibidores de serina proteasa del virus de la hepatitis c
|
KR20090024834A
(ko)
|
2006-07-05 |
2009-03-09 |
인터뮨, 인크. |
C형 간염 바이러스 복제의 신규 억제제
|
CN101484444B
(zh)
*
|
2006-07-07 |
2012-11-21 |
吉里德科学公司 |
哒嗪化合物及其用途
|
ES2339298T3
(es)
*
|
2006-07-07 |
2010-05-18 |
Gilead Sciences, Inc. |
Compuesto de piridazina novedoso y uso del mismo.
|
WO2008008776A2
(fr)
|
2006-07-11 |
2008-01-17 |
Bristol-Myers Squibb Company |
Inhibiteurs du virus de l'hépatite c
|
EA017448B1
(ru)
|
2006-07-13 |
2012-12-28 |
Ачиллион Фармасьютикалз, Инк. |
4-амино-4-оксобутаноиловые пептиды как ингибиторы вирусной репликации
|
US7718612B2
(en)
*
|
2007-08-02 |
2010-05-18 |
Enanta Pharmaceuticals, Inc. |
Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
|
WO2008019303A2
(fr)
*
|
2006-08-04 |
2008-02-14 |
Enanta Pharmaceuticals, Inc. |
Inhibiteurs de sérine protéases de l'hépatite c macrocycliques de type pyridazinonyle
|
RU2009109355A
(ru)
|
2006-08-17 |
2010-09-27 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
Ингибиторы вырусной полимеразы
|
US8343477B2
(en)
|
2006-11-01 |
2013-01-01 |
Bristol-Myers Squibb Company |
Inhibitors of hepatitis C virus
|
US7772180B2
(en)
|
2006-11-09 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7763584B2
(en)
|
2006-11-16 |
2010-07-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8003604B2
(en)
|
2006-11-16 |
2011-08-23 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7888464B2
(en)
|
2006-11-16 |
2011-02-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
KR20090101372A
(ko)
*
|
2007-01-08 |
2009-09-25 |
페노믹스 코포레이션 |
매크로시클릭 c형 간염 프로테아제 억제제
|
CN105037347B
(zh)
*
|
2007-02-01 |
2018-06-01 |
泰博特克药品有限公司 |
Hcv巨环抑制剂的多晶形
|
EP2495249A1
(fr)
|
2007-02-26 |
2012-09-05 |
Achillion Pharmaceuticals, Inc. |
Peptides à amine tertiaire substituée utiles en tant qu'inhibiteurs de la réplication du VHC
|
CN102872461A
(zh)
|
2007-05-04 |
2013-01-16 |
弗特克斯药品有限公司 |
用于治疗hcv感染的组合治疗
|
EP2162431B1
(fr)
|
2007-06-29 |
2017-06-07 |
Gilead Sciences, Inc. |
Composés antiviraux
|
US8513186B2
(en)
|
2007-06-29 |
2013-08-20 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US8242140B2
(en)
|
2007-08-03 |
2012-08-14 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US8383583B2
(en)
|
2007-10-26 |
2013-02-26 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors
|
WO2009070692A1
(fr)
|
2007-11-29 |
2009-06-04 |
Enanta Pharmaceuticals, Inc. |
Inhibiteurs de sérine protéase de l'hépatite c macrocycliques, dérivés de la proline, substitués en c5
|
WO2009070689A1
(fr)
|
2007-11-29 |
2009-06-04 |
Enanta Pharmaceuticals, Inc. |
Dérivés de proline bicycliques substitués en c5 en tant qu'inhibiteurs de la protéase ns3 du virus de l'hépatite c
|
WO2009076173A2
(fr)
|
2007-12-05 |
2009-06-18 |
Enanta Pharmaceuticals, Inc. |
Composés à base de tripeptides fluorés inhibant la sérine protéase du vhc
|
US8476257B2
(en)
|
2007-12-19 |
2013-07-02 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US8202996B2
(en)
|
2007-12-21 |
2012-06-19 |
Bristol-Myers Squibb Company |
Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
|
EP2250174B1
(fr)
*
|
2008-02-04 |
2013-08-28 |
IDENIX Pharmaceuticals, Inc. |
Inhibiteurs de sérine protéase macrocycliques
|
US8163921B2
(en)
|
2008-04-16 |
2012-04-24 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
JP5529120B2
(ja)
|
2008-05-29 |
2014-06-25 |
ブリストル−マイヤーズ スクイブ カンパニー |
C型肝炎ウイルス阻害剤
|
US7964560B2
(en)
|
2008-05-29 |
2011-06-21 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8207341B2
(en)
|
2008-09-04 |
2012-06-26 |
Bristol-Myers Squibb Company |
Process or synthesizing substituted isoquinolines
|
UY32099A
(es)
*
|
2008-09-11 |
2010-04-30 |
Enanta Pharm Inc |
Inhibidores macrocíclicos de serina proteasas de hepatitis c
|
US8044087B2
(en)
|
2008-09-29 |
2011-10-25 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8563505B2
(en)
|
2008-09-29 |
2013-10-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CA2746265A1
(fr)
*
|
2008-12-10 |
2010-06-17 |
Achillion Pharmaceuticals, Inc. |
Analogues cycliques de peptides a-amino-4-oxobutanoyl, inhibiteurs de la replication virale
|
SI2364309T1
(sl)
|
2008-12-10 |
2015-03-31 |
Achillion Pharmaceuticals, Inc. |
Novi 4-amino-4-oksobutanoil peptidi kot inhibitorji virusne replikacije
|
US8283310B2
(en)
|
2008-12-15 |
2012-10-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
SG172848A1
(en)
|
2009-01-07 |
2011-08-29 |
Scynexis Inc |
Cyclosporine derivative for use in the treatment of hcv and hiv infection
|
US8377962B2
(en)
|
2009-04-08 |
2013-02-19 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors
|
EP2429568B1
(fr)
|
2009-05-13 |
2016-08-17 |
Enanta Pharmaceuticals, Inc. |
Composés macrocycliques comme inhibiteurs du virus de l'hépatite c
|
AR077712A1
(es)
|
2009-08-05 |
2011-09-14 |
Idenix Pharmaceuticals Inc |
Inhibidores de serina proteasa macrociclica
|
US8389560B2
(en)
|
2009-09-15 |
2013-03-05 |
Taigen Biotechnology Co., Ltd. |
HCV protease inhibitors
|
JP2013528217A
(ja)
|
2010-06-07 |
2013-07-08 |
アッヴィ・インコーポレイテッド |
大環状c型肝炎セリンプロテアーゼ阻害薬
|
PE20140015A1
(es)
|
2010-09-21 |
2014-02-16 |
Enanta Pharm Inc |
Inhibidores de las proteasas de serina del vhc derivados de prolinas macrociclicas
|
MX2013007677A
(es)
|
2010-12-30 |
2013-07-30 |
Abbvie Inc |
Inhibidores macrociclicos de serina proteasa de hepatitis.
|
AU2011352145A1
(en)
|
2010-12-30 |
2013-07-18 |
Abbvie Inc. |
Phenanthridine macrocyclic hepatitis C serine protease inhibitors
|
WO2012109398A1
(fr)
|
2011-02-10 |
2012-08-16 |
Idenix Pharmaceuticals, Inc. |
Inhibiteurs macrocycliques de sérine protéase, compositions pharmaceutiques les contenant et leur utilisation pour le traitement des infections par le vhc
|
US8957203B2
(en)
|
2011-05-05 |
2015-02-17 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
US8691757B2
(en)
|
2011-06-15 |
2014-04-08 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
MX360452B
(es)
*
|
2012-10-19 |
2018-11-01 |
Bristol Myers Squibb Co |
Inhibidores del virus de la hepatitis c.
|
WO2014071007A1
(fr)
|
2012-11-02 |
2014-05-08 |
Bristol-Myers Squibb Company |
Inhibiteurs du virus de l'hépatite c
|
US9643999B2
(en)
|
2012-11-02 |
2017-05-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US9598433B2
(en)
|
2012-11-02 |
2017-03-21 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2014070974A1
(fr)
|
2012-11-05 |
2014-05-08 |
Bristol-Myers Squibb Company |
Inhibiteurs du virus de l'hépatite c
|
WO2014137869A1
(fr)
|
2013-03-07 |
2014-09-12 |
Bristol-Myers Squibb Company |
Inhibiteurs du virus de l'hépatite c
|
EA201591722A1
(ru)
|
2013-03-14 |
2016-02-29 |
Ачиллион Фармасьютикалз, Инк. |
Новые способы получения совапревира
|
US9006423B2
(en)
|
2013-03-15 |
2015-04-14 |
Achillion Pharmaceuticals Inc. |
Process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
|
WO2014145600A1
(fr)
|
2013-03-15 |
2014-09-18 |
Achillion Pharmaceuticals, Inc. |
Polymorphes de sel de sodium d'ach-0142684, composition les comprenant, et leur procédé de fabrication
|
KR20160005686A
(ko)
|
2013-03-15 |
2016-01-15 |
아칠리온 파르마세우티칼스 인코포레이티드 |
소바프레비르 다형체들 및 이의 제조 방법
|
EP3089757A1
(fr)
|
2014-01-03 |
2016-11-09 |
AbbVie Inc. |
Formes galéniques antivirales solides
|
EP2899207A1
(fr)
|
2014-01-28 |
2015-07-29 |
Amikana.Biologics |
Nouveau procédé pour tester l'inhibition de la protéase du HCV
|
CN105130916B
(zh)
*
|
2015-09-30 |
2019-03-01 |
江西师范大学 |
一种高效制备nh-1,2,3三唑化合物的方法
|
TWI832917B
(zh)
|
2018-11-06 |
2024-02-21 |
美商富曼西公司 |
經取代之甲苯基殺真菌劑
|
WO2021127273A1
(fr)
*
|
2019-12-20 |
2021-06-24 |
Gb004, Inc. |
Dérivés de 1-((6-oxo-1,6-dihydropyridazin-4-yl)méthyl)pipérazine et de 1-((6-oxo-1,6-dihydropyrimidin-4-yl)méthyl)pipérazine utilisés en tant que modulateurs de la prolyl hydroxylase, de l'hif-1 alpha et de la pgk dans le traitement de maladies inflammatoires, du cancer ou d'infections
|
UY39189A
(es)
|
2020-05-06 |
2021-12-31 |
Fmc Corp |
Fungicidas de tolilo sustituido y sus mezclas
|